A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States

Autor: Brown, Gary C., Brown, Melissa M., Rapuano, Sara B., Boyer, David
Zdroj: In American Journal of Ophthalmology March 2021 223:405-429
Databáze: ScienceDirect